Therapeutic activity of a new KRASG12C inhibitor JMKX001899 in brain metastases: Preclinical models of KRASG12C-mutant non-small cell lung cancer

被引：0
|
作者：
He, Danming
Wang, Jie
Zhu, Yixiang
Zhong, Jia
Bai, Hua
机构：
[1] Chinese Acad Med Sci, State Key Lab Mol Oncol, CAMS Key Lab Translat Res Lung Canc,Canc Hosp, Natl Canc Ctr,Natl Clin Res Ctr Canc,Dept Med Onc, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp,State Key Lab Mo, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8630
引用
收藏
页数：1
相关论文
共 50 条
  • [21] KRAS inhibitor-resistance in MET-amplified KRASG12C non-small cell lung cancer
    Suzuki, Shinichiro
    Yonesaka, Kimio
    CANCER SCIENCE, 2022, 113 : 1260 - 1260
  • [22] Preclinical efficacy of KRASG12C inhibitors in models of pediatric cancer
    Price, Hannah
    Stauffer, Stacey
    Powell, Katie
    Baker, Andrew
    Perciaccante, Andrew
    Hernandez, Edjay Ralph
    Odeniyide, Patience
    Pratilas, Christine
    Burgan, William
    Jenkins, Lisa
    Rossman, Kent L.
    Yohe, Marielle
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [23] An evaluation of sotorasib for the treatment of patients with non-small cell lung cancer with KRASG12C mutations
    Strohbehn, Garth W.
    Sankar, Kamya
    Qin, Angel
    Kalemkerian, Gregory P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (14) : 1569 - 1575
  • [24] Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer
    Zhang, Shannon S.
    Nagasaka, Misako
    LUNG CANCER-TARGETS AND THERAPY, 2021, 12 : 115 - 122
  • [25] Targeting Krasg12c-mutant cancer with a mutation-specific inhibitor
    Christensen, J. G.
    Olson, P.
    Briere, T.
    Wiel, C.
    Bergo, M. O.
    JOURNAL OF INTERNAL MEDICINE, 2020, 288 (02) : 183 - 191
  • [26] DEVELOPMENT OF COMBINATION THERAPIES OF KRASG12C INHIBITOR ADAGRASIB IN PRECLINICAL MODELS OF BRAIN METASTASIS
    Torrini, Consuelo
    Migliarese, Christian
    Summers, Elizabeth
    Demir, Fatma Turna
    Ijad, Nazanin
    Nayyar, Naema
    Yamazawa, Erika
    De Sauvage, Magali
    Brastianos, Priscilla
    Wakimoto, Hiroaki
    NEURO-ONCOLOGY, 2023, 25
  • [27] Influence of Brain Metastases on Survival of KRASG12C Mutated Stage IV Immune Checkpoint Inhibitor Treated Non-Small Cell Lung Cancer Patients
    Swart, E.
    Noordhof, A. L.
    Damhuis, R. A. M.
    Kunst, P. W. A.
    De Ruysscher, D. K. M.
    Hendriks, L. E. L.
    van Geffen, W. H.
    Aarts, M. J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S349 - S349
  • [28] Safety, Efficacy, and Pharmacokinetics of AMG 510, a Novel KRASG12C Inhibitor, in Patients with Non-Small Cell Lung Cancer
    Govindan, R.
    Fakih, M.
    Price, T.
    Falchook, G.
    Desai, J.
    Kuo, J.
    Strickler, J.
    Krauss, J.
    Li, B.
    Denlinger, C.
    Durm, G.
    Ngang, J.
    Henary, H.
    Ngarmchamnanrith, G.
    Rasmussen, E.
    Morrow, P. K.
    Hong, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1125 - S1126
  • [29] VT204: A Potential Small Molecule Inhibitor Targeting KRASG12C Mutation for Therapeutic Intervention in Non-Small Cell Lung Cancer
    Yang, Xuechao
    Zhang, Shu
    Yang, Yang
    Duan, Xiaoqun
    Li, Xiaochuan
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [30] Adagrasib in Non-Small-Cell Lung Cancer Harboring a KRASG12C Mutation
    Jaenne, Pasi A.
    Riely, Gregory J.
    Gadgeel, Shirish M.
    Heist, Rebecca S.
    Ou, Sai-Hong I.
    Pacheco, Jose M.
    Johnson, Melissa L.
    Sabari, Joshua K.
    Leventakos, Konstantinos
    Yau, Edwin
    Bazhenova, Lyudmila
    Negrao, Marcelo V.
    Pennell, Nathan A.
    Zhang, Jun
    Anderes, Kenna
    Der-Torossian, Hirak
    Kheoh, Thian
    Velastegui, Karen
    Yan, Xiaohong
    Christensen, James G.
    Chao, Richard C.
    Spira, Alexander I.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (02) : 120 - 131
12345